Day: January 17, 2024

MELBOURNE, Australia and NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies is pleased to announce that an independent Institutional Review Board (IRB) has approved the protocol for the Company’s Phase 2/3 clinical trial to be conducted in the United States to assess safety and efficacy of proprietary combination drug candidate IHL-42X in patients with obstructive sleep apnea (OSA). IRB approval of the protocol is a key step in activation of clinical trial sites for the RePOSA study. Under regulations of the Food & Drug Administration, IRB approval is required prior to commencing research in human subjects and serves to ensure that appropriate...

TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCBQ: HGCPF) (the “Company” or “HydroGraph”), a manufacturer of pristine graphene, today issued the following letter to its stakeholders from HydroGraph CEO Stuart Jara. Dear HydroGraph Stakeholders, Colleagues and Friends: Reflecting on 2023, I am incredibly proud of the significant progress HydroGraph has made to position us squarely on the path to secure our first major customer contracts. We have achieved key operational milestones, advanced our application development and established new commercial and strategic partnerships, despite the challenging macroeconomic and geopolitical environments. On the foundation of the progress made in 2023, the goals set for 2024 should position us to secure the first significant contract in 2024. We will also...

CERVAI™ Brain HealthCERVAI™ Brain HealthTORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital health artificial intelligence company focused on brain health, today announced the pilot launch of CERVAI™, a world-first consumer brain health and wellness AI solution that aims to ‘raise a red flag’ for potential brain health issues by estimating brain age and providing a brain health score. Fabio Chianelli, Chairman and CEO of DiagnaMed, commented: “After over two years in development, CERVAI™, a world-first consumer brain health and wellness solution that estimates brain age and provides a brain health score, is available to clinics seeking to provide a unique service that helps bridge the gaps in physical and cognitive...

GURU Organic EnergyGURU’s punch lineup: Peach Mango Punch, Tropical Punch and Fruit PunchPeach Mango Punch offers an amazing flavor explosion, with GURU’s unique blend of natural ingredients to increase focus and brain performance. Newest addition to punch line, Peach Mango Punch, and recently launched Fruit Punch, will both be available to US retailers starting in February. GURU’s entire punch lineup, consisting of Tropical Punch, Fruit Punch and Peach Mango Punch, will also be showcased to US retailers at TheFitExpo, KeHE, UNFI, and Expo West trade shows.MONTRÉAL, Jan. 17, 2024 (GLOBE NEWSWIRE) — GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company”), Canada’s leading organic energy drink brand1, today announced the launch of its new Peach Mango Punch in the US, available on Amazon.com and directly on the...

TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the launch of Venus Prime, a structured in-house financing program replacing its legacy subscription program for new customers in North America. Under our Venus Prime program, select customers can qualify for competitive financing rates and continue to benefit from the payment flexibility afforded by our previous subscription financing program when purchasing our aesthetic medical devices, as well as a seamless technology upgrade program made available to our customers in years 2 and 3 of ownership. Venus Prime is now available to qualifying customers who may not currently be eligible for financing by traditional third-party lenders...

Meddelelse om fejl NAV den 27. og 28. december 2023 I nedenstående andelsklasse har der, i tidsrummet 27. december til 28. december kl. 16:22, været offentliggjort fejlagtige NAV-værdier.ISIN Afdeling Afvigelse i NAV For lav eller for højDK0060037455 Maj Invest Kontra Strategier 0,5-1,092% For lavDer er i mindre omfang foretaget indløsninger i andelsklassen. Med venlig hilsen Investeringsforeningen Maj Investv/ Investeringsforvaltningsselskabet SEBinvest A/S

Parsippany, NJ, Jan. 17, 2024 (GLOBE NEWSWIRE) — GOe3, the Scottsdale-based electric vehicle (EV) infrastructure company, is at the forefront of revolutionizing the travel industry through an innovative EV charging solution that benefits both business and consumer while addressing the struggles of the nation’s current energy grid. The Company is expanding its horizons in 2024, starting with a merger with Global Technologies Ltd. (GTLL: OTC Pink) in the first quarter of the year and an upcoming expansion of production capabilities. “We don’t have a problem generating the energy, we have a problem properly distributing it,” said Brian Brimacombe, GOe3 Chief Executive Officer. “We’re trying to change that through the use of solutions like bidirectional charging and technology designs that allow our charging stations to be virtually...

Ra’anana, Israel , Jan. 17, 2024 (GLOBE NEWSWIRE) — Rail Vision Ltd. (the “Company”) (Nasdaq: RVSN), a technology company seeking to revolutionize the railway safety market, announced today that a leading US-based rail and leasing services company signed a supply contract with Rail Vision valued at up to $5,000,000 (USD) for the purchase of Rail Vision’s AI-based Switch Yard Systems.  “The signing of the contract with this customer is a significant milestone for Rail Vision, marking our entrance into the US market and reflecting our commitment to enabling the rail industry with cutting-edge AI-based technology,” said Rail Vision CEO Shahar Hania. “Our Switch Yard System is designed to significantly improve safety and efficiency in rail yards. We are proud that our new customer, a prominent player in the rail...

CytoSorb Blood Purification Results in Statistically Significant Reductions in Multiple Organ Failure and Dysfunction PRINCETON, N.J., Jan. 17, 2024 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, reports on excellent outcomes from a groundbreaking randomized controlled trial (RCT) using CytoSorb® blood purification during heart transplant, recently published in the European Society of Cardiology journal, ESC Heart Failure. As co-lead authors Drs. Endre Németh and Adam Soltesz from the Heart and Vascular Center at Semmelweis University, Budapest, Hungary explain, as more complex and higher risk patients become eligible for heart transplant,...